Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery

Clinical Trial ID NCT00956930

Rank	Title	Journal	Year	PubWeight™‹?›
1	Trial watch: Chemotherapy with immunogenic cell death inducers.	Oncoimmunology	2012	1.33
2	Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.	Gastroenterology	2016	1.15
3	Management of Hepatocellular Carcinoma: Current Status and Future Directions.	Gut Liver	2015	0.92
4	Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review.	Korean J Radiol	2016	0.81
5	Transarterial approaches to primary and secondary hepatic malignancies.	Nat Rev Clin Oncol	2015	0.78
6	Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions.	Br J Radiol	2015	0.78
7	Yttrium-90 microsphere radioembolization for hepatocellular carcinoma.	Liver Cancer	2015	0.78
8	Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives.	World J Hepatol	2015	0.77
9	Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments.	J Hepatocell Carcinoma	2014	0.75